Latest news
Palvella Therapeutics (PVLA) Earnings And QTORIN Hopes Keep Undervaluation In Focus - simplywall.stsimplywall.st · Sat, 08 Aug 2026 12:26:25 GMTIs Palvella Therapeutics (PVLA) Fully Valued Ahead Of QTORIN Approval? - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 11:10:58 GMTFull Transcript: Palvella Therapeutics Q2 2026 Earnings Call - SahmSahm · Wed, 05 Aug 2026 19:28:03 GMTPVLA: QTORIN rapamycin advanced toward FDA approval with strong phase III data, robust cash, and launch readiness - TradingViewTradingView · Tue, 04 Aug 2026 14:07:33 GMT